Compare TTK HEALTHCARE with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs BIOCON - Comparison Results

BIOCON  
   Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE BIOCON TTK HEALTHCARE/
BIOCON
 
P/E (TTM) x 12.7 31.5 40.5% View Chart
P/BV x 1.8 3.7 49.3% View Chart
Dividend Yield % 0.8 0.3 318.5%  

Financials

 TTK HEALTHCARE   BIOCON
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
BIOCON
Mar-19
TTK HEALTHCARE/
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,215707 171.8%   
Low Rs610554 110.2%   
Sales per share (Unadj.) Rs444.491.9 483.5%  
Earnings per share (Unadj.) Rs17.216.7 103.2%  
Cash flow per share (Unadj.) Rs27.624.2 114.3%  
Dividends per share (Unadj.) Rs5.001.00 500.0%  
Dividend yield (eoy) %0.50.2 345.5%  
Book value per share (Unadj.) Rs177.9101.6 175.1%  
Shares outstanding (eoy) m14.13600.00 2.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.16.9 29.9%   
Avg P/E ratio x52.937.7 140.2%  
P/CF ratio (eoy) x33.026.1 126.6%  
Price / Book Value ratio x5.16.2 82.7%  
Dividend payout %29.06.0 484.4%   
Avg Mkt Cap Rs m12,894378,330 3.4%   
No. of employees `0002.36.1 37.7%   
Total wages/salary Rs m1,30711,653 11.2%   
Avg. sales/employee Rs Th2,715.78,994.3 30.2%   
Avg. wages/employee Rs Th565.31,900.7 29.7%   
Avg. net profit/employee Rs Th105.41,635.3 6.4%   
INCOME DATA
Net Sales Rs m6,27955,144 11.4%  
Other income Rs m781,444 5.4%   
Total revenues Rs m6,35656,588 11.2%   
Gross profit Rs m49615,883 3.1%  
Depreciation Rs m1474,478 3.3%   
Interest Rs m34709 4.8%   
Profit before tax Rs m39312,140 3.2%   
Minority Interest Rs m09 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1492,123 7.0%   
Profit after tax Rs m24410,026 2.4%  
Gross profit margin %7.928.8 27.4%  
Effective tax rate %37.917.5 216.9%   
Net profit margin %3.918.2 21.3%  
BALANCE SHEET DATA
Current assets Rs m2,71748,228 5.6%   
Current liabilities Rs m1,57130,376 5.2%   
Net working cap to sales %18.332.4 56.4%  
Current ratio x1.71.6 109.0%  
Inventory Days Days3268 47.1%  
Debtors Days Days4786 54.6%  
Net fixed assets Rs m99164,130 1.5%   
Share capital Rs m1413,000 4.7%   
"Free" reserves Rs m2,37357,980 4.1%   
Net worth Rs m2,51460,980 4.1%   
Long term debt Rs m315,766 0.0%   
Total assets Rs m4,158121,924 3.4%  
Interest coverage x12.618.1 69.6%   
Debt to equity ratio x00.3 0.5%  
Sales to assets ratio x1.50.5 333.9%   
Return on assets %6.78.8 75.8%  
Return on equity %9.716.4 59.0%  
Return on capital %16.916.8 101.1%  
Exports to sales %3.628.1 12.8%   
Imports to sales %0.518.9 2.6%   
Exports (fob) Rs m22515,506 1.5%   
Imports (cif) Rs m3110,399 0.3%   
Fx inflow Rs m22515,506 1.5%   
Fx outflow Rs m7110,399 0.7%   
Net fx Rs m1545,107 3.0%   
CASH FLOW
From Operations Rs m17311,546 1.5%  
From Investments Rs m97-7,138 -1.4%  
From Financial Activity Rs m-307-2,417 12.7%  
Net Cashflow Rs m-382,103 -1.8%  

Share Holding

Indian Promoters % 65.4 40.4 161.9%  
Foreign collaborators % 0.0 20.6 -  
Indian inst/Mut Fund % 3.7 8.4 44.0%  
FIIs % 5.2 10.7 48.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 19.9 129.6%  
Shareholders   12,723 109,995 11.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ABBOTT INDIA  JUBILANT PHARMOVA   AJANTA PHARMA  PFIZER  ALKEM LABORATORIES  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (3QFY21); Net Profit Up 71.7% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, TTK HEALTHCARE has posted a net profit of Rs 77 m (up 71.7% YoY). Sales on the other hand came in at Rs 2 bn (up 8.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (3QFY20); Net Profit Down 8.3% (Quarterly Result Update)

Jan 30, 2020 | Updated on Jan 30, 2020

For the quarter ended December 2019, TTK HEALTHCARE has posted a net profit of Rs 45 m (down 8.3% YoY). Sales on the other hand came in at Rs 2 bn (up 11.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


May 7, 2021 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - FDC COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS